Minerva Neurosciences, Inc. SEC filings NERV
Minerva Neurosciences, Inc. has 645 filings in SEC EDGAR's recent list, going back to Feb 14, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 3, 2026 | Nov 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| 3 | Initial insider ownership | Aug 20, 2026 | Aug 10, 2026 |
| 3 | Initial insider ownership | Aug 20, 2026 | Aug 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Aug 12, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Aug 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 27, 2026 | May 27, 2026 |
| 424B5 | Prospectus supplement | May 27, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 21, 2026 |
| 3 | Initial insider ownership | Apr 22, 2026 | Apr 21, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Other events
|
Apr 6, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Apr 2, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| EFFECT | Filing | Mar 19, 2026 | — |
| CORRESP | Letter to the SEC | Mar 17, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2026 | — |
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 11, 2026 |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 3, 2026 | Feb 3, 2026 |
| EFFECT | Filing | Jan 6, 2026 | — |
| 424B3 | Prospectus | Jan 6, 2026 | — |
| CORRESP | Letter to the SEC | Jan 2, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 31, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 30, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 29, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 29, 2025 | — |
| S-8 | Employee stock plan registration | Dec 23, 2025 | — |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| S-3 | Shelf registration | Dec 23, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 22, 2025 | Dec 22, 2025 |
| ARS | Annual report to shareholders | Nov 24, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Nov 24, 2025 | Dec 22, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 19, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 3 | Initial insider ownership | Nov 18, 2025 | Nov 14, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 14, 2025 | Dec 22, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Oct 28, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 22, 2025 | Oct 21, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 19, 2025 | Mar 17, 2025 |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Jan 13, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 5, 2024 | Dec 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Oct 22, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Oct 22, 2024 | — |
| DEF 14A | Proxy statement | Oct 22, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 11, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Other events
|
Sep 16, 2024 | Sep 14, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
May 30, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 1, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Apr 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 12, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Other events
|
Feb 27, 2024 | Feb 26, 2024 |
| 10-K/A | Amended annual report | Feb 26, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 18, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 4 | Insider transaction | Oct 5, 2023 | Oct 4, 2023 |
| 4 | Insider transaction | Oct 5, 2023 | Oct 4, 2023 |
| 4 | Insider transaction | Oct 5, 2023 | Oct 4, 2023 |
| 4 | Insider transaction | Sep 29, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Sep 29, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Sep 29, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Sep 29, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Sep 29, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 28, 2023 | Sep 27, 2023 |
| ARS | Annual report to shareholders | Aug 15, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Aug 15, 2023 | — |
| DEF 14A | Proxy statement | Aug 15, 2023 | Sep 27, 2023 |
| EFFECT | Filing | Aug 9, 2023 | — |
| 424B3 | Prospectus | Aug 9, 2023 | — |
| CORRESP | Letter to the SEC | Aug 7, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2023 | — |
| S-3 | Shelf registration | Aug 4, 2023 | — |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| SC 13D | Ownership over 5% (active) | Jul 7, 2023 | — |
| 3 | Initial insider ownership | Jul 7, 2023 | Jun 27, 2023 |
| D | Filing | Jul 3, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 28, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Other events
|
Jun 20, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Listing notice
|
Jun 2, 2023 | May 31, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Officer or director change
|
May 5, 2023 | May 3, 2023 |
| 4 | Insider transaction | May 2, 2023 | Apr 28, 2023 |
| 4 | Insider transaction | May 2, 2023 | Apr 28, 2023 |
| 4 | Insider transaction | May 2, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Other events
|
May 1, 2023 | May 1, 2023 |
| 10-K/A | Amended annual report | Apr 20, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 8, 2023 | Dec 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 1, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 28, 2022 | Dec 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2022 | Dec 13, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 13, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 13, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Listing notice
|
Dec 2, 2022 | Dec 1, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Oct 17, 2022 | Oct 14, 2022 |
| EFFECT | Filing | Sep 23, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| CORRESP | Letter to the SEC | Sep 21, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| S-3 | Shelf registration | Sep 14, 2022 | — |
| CORRESP | Letter to the SEC | Sep 14, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2022 | — |
| 8-K |
Current report
Listing notice
|
Sep 9, 2022 | Sep 8, 2022 |
| SC 13G | Ownership over 5% (passive) | Aug 23, 2022 | — |
| 8-K |
Current report
Other events
|
Aug 22, 2022 | Aug 22, 2022 |
| 4 | Insider transaction | Aug 16, 2022 | Aug 11, 2022 |
| 3 | Initial insider ownership | Aug 10, 2022 | Aug 8, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 10, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 17, 2022 | Jun 17, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 10, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 10, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2022 | Apr 13, 2022 |
| 8-K |
Current report
Other events
|
Apr 7, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Listing notice
|
Mar 14, 2022 | Mar 8, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Other events
|
Feb 28, 2022 | Feb 28, 2022 |
| 4 | Insider transaction | Feb 18, 2022 | Feb 16, 2022 |
| 4 | Insider transaction | Feb 18, 2022 | Feb 16, 2022 |
| 4 | Insider transaction | Feb 18, 2022 | Feb 16, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2022 | — |
| 8-K |
Current report
Listing notice
|
Jan 18, 2022 | Jan 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2021 | Dec 8, 2021 |
| 4 | Insider transaction | Dec 3, 2021 | Dec 1, 2021 |
| SC 13G | Ownership over 5% (passive) | Nov 24, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Nov 24, 2021 | — |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Other events
|
Nov 3, 2021 | Nov 3, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NERV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Burlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1598646
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.